Article Information
History
- October 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Cora C. Hart1,2,4,
- Young il Lee1,2,4,
- Jun Xie3,
- Guangping Gao3,
- David W. Hammers1,2,5 and
- H. Lee Sweeney1,2,5,*
- 1Department of Pharmacology & Therapeutics, University of Florida College of Medicine; Gainesville, FL 32610
- 2Myology Institute, University of Florida College of Medicine; Gainesville, FL 32610
- 3Horae Gene Therapy Center, University of Massachusetts Medical School, Worchester, MA 01655
- ↵*Corresponding author Correspondence:
H. Lee Sweeney, 1200 Newell Dr. ARB R5-216, Gainesville, FL 32610-0267, Phone: 352-273-9416, Fax: 352-392-3558, Email: lsweeney{at}ufl.edu
Posted October 05, 2022.
Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy
